Irvine, Calif. - Turf battles over who should administer botulinumtoxin injections erupted within the first month after the April 15 FDA approvalof Botox Cosmetic.
Derm In The News: May 12-18
The Cutaneous Connection: A Reminder of Patient Impact
Baldo Scassellati Sforzolini, MD, PhD, MBA: Expanding Nemolizumab’s Access
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
Dermatophytoma: A Diagnosis That You Do Not Want to Miss
QUIZ RECAP: Advanced Skin Cancer Awareness